| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/28/2014 | US8637239 Minimally-invasive measurement of esophageal inflammation |
| 01/28/2014 | US8637234 Molecular scaffolds for HIV-1 epitopes |
| 01/28/2014 | US8637232 Biomarkers for lung disease monitoring |
| 01/28/2014 | US8637035 Anti-dengue virus antibodies |
| 01/28/2014 | US8636956 Sensor for measuring carbon dioxide in respiratory gas |
| 01/28/2014 | US8636758 System for withdrawing blood |
| 01/28/2014 | US8636673 Tissue penetration device |
| 01/28/2014 | CA2807564C Microfluidic devices and methods of using same |
| 01/28/2014 | CA2666336C Use of surface display proteins to display inorganic catalysts on the surface of a yeast, bacterium or virion |
| 01/28/2014 | CA2659201C Device for recording measurement data |
| 01/28/2014 | CA2609653C Optical microscopy with phototransformable optical labels |
| 01/28/2014 | CA2547632C Sling with predictable pre-failure warning indicator |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/28/2014 | CA2530789C Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 01/28/2014 | CA2527351C Process for analyzing hemoglobin by capillary electrophoresis, capillary electrophoresis kit and use of flow rate reducer in such a process |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2489915C Method of assessing skin and overall health of an individual |
| 01/28/2014 | CA2456593C Peptides for the diagnosis, monitoring and treatment of diabetes |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/28/2014 | CA2354060C Apparatus and method for control of tissue/implant interactions |
| 01/23/2014 | WO2014015328A1 Cell based quality control bioassays for nutriceutical and medicinal products |
| 01/23/2014 | WO2014015229A1 Isolation of stromal vascular fraction from adipose tissue obtained from postmortem source using ultrasonic cavitation |
| 01/23/2014 | WO2014015217A1 Biomarkers for hcv infected patients |
| 01/23/2014 | WO2014015194A2 Methods for detecting and measuring aggregation |
| 01/23/2014 | WO2014015187A1 Manipulation of microparticles in low field dielectrophoretic regions |
| 01/23/2014 | WO2014015177A1 Rapid measurement of formed blood component sedimentation rate from small sample volumes |
| 01/23/2014 | WO2014015124A1 Gypsum manufacturing process improvement |
| 01/23/2014 | WO2014015076A1 Lateral flow assays using two dimensional features |
| 01/23/2014 | WO2014015024A2 Non-surgical method of treatment for cataract |
| 01/23/2014 | WO2014014966A1 Screening methods for therapeutic anti-inflammatory agents |
| 01/23/2014 | WO2014014931A1 Methods of biomarker validation and target discovery |
| 01/23/2014 | WO2014014919A1 Compositions, devices and methods for detecting antigens, small molecules, and peptides such as bacterial quorum sensing peptides |
| 01/23/2014 | WO2014014915A1 Direct reading detection kits for surface contamination by antineoplastic drugs |
| 01/23/2014 | WO2014014754A1 Methods of detecting dna, rna and protein in biological samples |
| 01/23/2014 | WO2014014563A1 Affinity support and method for trapping substance using the same |
| 01/23/2014 | WO2014014555A1 Device for measuring liquid property |
| 01/23/2014 | WO2014014518A1 Methods for treating, preventing and predicting risk of developing breast cancer |
| 01/23/2014 | WO2014014512A1 Fourier transform microwave spectroscopy for enantiomer-specific detection of chiral molecules |
| 01/23/2014 | WO2014014485A1 Testing of blood coagulation characteristics |
| 01/23/2014 | WO2014014484A1 Determining blood coagulation characteristics |
| 01/23/2014 | WO2014014371A1 A method of fabrication of an immunosensor and its use for detection of influenza virus |
| 01/23/2014 | WO2014014347A1 Single molecule protein sequencing |
| 01/23/2014 | WO2014014309A1 Method and kit for detecting or quantifying target material |
| 01/23/2014 | WO2014014207A1 Antibody for epitope tagging, hybridoma cell line and uses thereof |
| 01/23/2014 | WO2014014206A1 Novel peptide tag and uses thereof |
| 01/23/2014 | WO2014014189A1 Device and method for screening for bioactive materials using visual recognition of animals |
| 01/23/2014 | WO2014014157A1 Use of adcy3 for diagnosis and treatment of gastric cancer |
| 01/23/2014 | WO2014014106A1 Photocoupling method using probe containing photoresponsive nucleic acids |
| 01/23/2014 | WO2014014086A1 Cancer detection method |
| 01/23/2014 | WO2014014082A1 Cancer detection method |
| 01/23/2014 | WO2014013897A1 Nucleic acid chromatographic test tool, and method for producing same |
| 01/23/2014 | WO2014013681A1 Protective cover for biological information measurement device and biological information measurement devices furnished with same |
| 01/23/2014 | WO2014013635A1 In vitro diagnostic tool, membrane for in vitro diagnostic tool, and methods for manufacturing same |
| 01/23/2014 | WO2014013456A2 Surface supported liposome nanoarrays as biomimetic sensors |
| 01/23/2014 | WO2014013372A1 Processing of a sample fluid with target components |
| 01/23/2014 | WO2014013334A2 In vitro assay for predicting renal proximal tubular cell toxicity |
| 01/23/2014 | WO2014013329A1 In vitro assay for predicting renal proximal tubular cell toxicity |
| 01/23/2014 | WO2014013272A1 Rhodamine based fluorescent probe for coagulase activity and detection of coagulase producing bacterial strains |
| 01/23/2014 | WO2014013231A1 Materials and methods for treating pten mutated or deficient cancer |
| 01/23/2014 | WO2014013225A1 Triage scoring system |
| 01/23/2014 | WO2014013184A1 Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder |
| 01/23/2014 | WO2014013180A1 Theranostic method based on the detection of her2-her2 dimers |
| 01/23/2014 | WO2014013079A1 Method for increasing implantation success in assisted fertilization |
| 01/23/2014 | WO2014013063A1 Test kit for the quantitative determination of narcotic drugs |
| 01/23/2014 | WO2014013051A1 Method of predicting or diagnosing an hepatic encephalopathy in patients with cirrhosis treated with transjugular intra-hepatic porto-systemic shunt (tips) |
| 01/23/2014 | WO2014013043A1 Giant liposome array for high-throughput lipid-interaction screening |
| 01/23/2014 | WO2014013036A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/23/2014 | WO2014013024A1 Method for purifying transgenic factor vii |
| 01/23/2014 | WO2014013016A1 Method for determining the her2 status of a malignancy |
| 01/23/2014 | WO2014012985A1 Method and device for measuring a medium of interest |
| 01/23/2014 | WO2014012951A1 Mems device with improved filter |
| 01/23/2014 | WO2014012928A1 Status of tuberculosis infection in an individual |
| 01/23/2014 | WO2014012902A2 Melanosome transport inhibition for the treatment of melanoma |
| 01/23/2014 | WO2014012892A1 Fucose as a biomarker for gut immunity |
| 01/23/2014 | WO2014012558A2 A dry stick device and a method for determining an analyte in a sample |
| 01/23/2014 | WO2014012356A1 Devices and methods for enhanced detection and identification of diseases |
| 01/23/2014 | WO2014012210A1 Immunoassay method based on absorbance measurement |
| 01/23/2014 | WO2014012176A1 Methods, kits and compositions for providing a clinical assessment of prostate cancer |
| 01/23/2014 | WO2014012168A1 Method for the isolation of microvesicles |
| 01/23/2014 | WO2014012147A1 Method of diagnosis and treatment |
| 01/23/2014 | WO2013188686A3 Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome |
| 01/23/2014 | WO2013172866A3 Sensors for detection of mesothelin |
| 01/23/2014 | WO2013171489A8 Methods to predict progression of barrett ' s esophagus to high grade dysplasia or esophageal adenocarcinoma |
| 01/23/2014 | WO2013166183A3 Replikin sequences and their antibodies, therapeutics and vaccines against prion and neurodegenerative disorders |
| 01/23/2014 | WO2013166030A3 Detecting complement activation |
| 01/23/2014 | WO2013165969A3 Methods and kits for diagnosing heparin-induced thrombocytopenia |
| 01/23/2014 | WO2013165625A3 Explosives detection polymer comprising functionalized polyamine polymers and methods of using the same |
| 01/23/2014 | WO2013164788A3 Method |
| 01/23/2014 | WO2013164763A3 A biological complex specific for alzheimer's disease detection in vitro and use thereof |
| 01/23/2014 | WO2013162905A8 Methods of producing and using regulatory b-cells |
| 01/23/2014 | WO2013156870A3 Detection of quantity of water flow using quantum clusters |
| 01/23/2014 | WO2013140316A3 Manufacturing method of an apparatus for the processing of single molecules |
| 01/23/2014 | WO2013124738A3 Methods and biomarkers for detection and prognosis of cervical cancer |
| 01/23/2014 | WO2013124727A3 Perfusion device, corresponding apparatus using said perfusion device and method to analyze the thrombotic-ischemic and hemorrhagic pathology |
| 01/23/2014 | WO2013110191A8 Abc terpenoid transporters and methods of using the same |
| 01/23/2014 | WO2013096240A9 Global crude oil quality monitoring |
| 01/23/2014 | WO2013057719A3 Sample quantification by disc centrifugation |
| 01/23/2014 | WO2013009703A8 Antibodies, kit and method for detecting amyloid beta oligomers |
| 01/23/2014 | US20140026234 Biomarkers and their uses in cancer detection and therapy |
| 01/23/2014 | US20140025345 Structural Model Of G Protein-Coupled Receptor And Method For Designing Ligand Capable Of Binding To G Protein-Coupled Receptor Using The Structural Model |